News

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

Gene therapy is being used against diseases like sickle cell and hemophilia. Could it be used against cancer?

Hollings researchers want to help older adults with head and neck cancer navigate treatment options that have mostly been studied among middle-aged adults.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

Hollings researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors.

MUSC Hollings Cancer Center researchers found that loosening up a CAR's grip on its Treg improved its function.

MUSC Hollings Cancer Center researcher Dr. Natalie Saini was awarded a Research Scholar Grant by the American Cancer Society.

On World Pancreatic Cancer Day, researchers and survivors gathered to share progress in the fight against pancreatic cancer.

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

New research shows how Tregs could transform care for type 1 diabetes and eventually cancer and autoimmune diseases.